Rubric Capital Management LP I Teos Therapeutics, Inc. Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$31.92 - $47.45 $11.2 Million - $16.6 Million
-350,208 Reduced 29.87%
822,112 $26.5 Million
Q4 2021

Feb 14, 2022
BUY
$26.23 - $47.86 $4.82 Million - $8.79 Million
183,637 Added 18.57%
1,172,320 $54.6 Million
Q3 2021

Nov 12, 2021
BUY
$23.91 - $29.58 $23.6 Million - $29.2 Million
988,683 New
988,683 $26.7 Million

Others Institutions Holding ITOS

# of Institutions
166
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email